Cartesian Therapeutics (1S70.F) Q2 2024 Earnings

8MayConfirmed
Q4 2023
Q2 2024
-9.77
-6.79
-3.8
-0.82

Details

Expected EPS
-0.8233155
Actual EPS
-9.76815
Surprise EPS
-8.94
Surprise Percent
+1,086.44%

Description

Cartesian Therapeutics (1S70.F) has reported earnings of -9.76815 per share for Q2 2024.

0 Comments

Share your thoughts